[(19S)-8-[(dimethylamino)methyl]-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-[6-[4-[(8S,11R,14S,17R)-17-acetyl-17-acetyloxy-3-oxo-2,6,7,8,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-11-yl]-N-methylanilino]hexanoyl]piperazine-1-carboxylate

C62H72N6O11 — CID 165146163

IUPAC[(19S)-8-[(dimethylamino)methyl]-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-[6-[4-[(8S,11R,14S,17R)-17-acetyl-17-acetyloxy-3-oxo-2,6,7,8,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-11-yl]-N-methylanilino]hexanoyl]piperazine-1-carboxylate
SMILESCC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(OC(=O)N4CCN(C(=O)CCCCCN(C)c5ccc([C@H]6CC7[C@@H](CC[C@]7(OC(C)=O)C(C)=O)[C@@H]7CCC8=CC(=O)CCC8=C76)cc5)CC4)ccc3nc2-1
InChIInChI=1S/C62H72N6O11/c1-7-61(76)50-32-53-57-40(33-68(53)58(73)49(50)35-77-59(61)74)30-47-48(34-64(4)5)54(21-20-52(47)63-57)78-60(75)67-27-25-66(26-28-67)55(72)11-9-8-10-24-65(6)41-15-12-38(13-16-41)46-31-51-44(22-23-62(51,36(2)69)79-37(3)70)45-18-14-39-29-42(71)17-19-43(39)56(45)46/h12-13,15-16,20-21,29-30,32,44-46,51,76H,7-11,14,17-19,22-28,31,33-35H2,1-6H3/t44-,45-,46+,51?,61-,62-/m0/s1
InChIKeyZOAZFTPLUZLAOM-JBAFGQRESA-N
MW1077.29 g/mol
LogP7.88
Rot. Bonds14

About [(19S)-8-[(dimethylamino)methyl]-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-[6-[4-[(8S,11R,14S,17R)-17-acetyl-17-acetyloxy-3-oxo-2,6,7,8,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-11-yl]-N-methylanilino]hexanoyl]piperazine-1-carboxylate

[(19S)-8-[(dimethylamino)methyl]-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-[6-[4-[(8S,11R,14S,17R)-17-acetyl-17-acetyloxy-3-oxo-2,6,7,8,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-11-yl]-N-methylanilino]hexanoyl]piperazine-1-carboxylate (PubChem CID 165146163) has the molecular formula C62H72N6O11 and a molecular weight of 1077.29 g/mol. Its IUPAC name is [(19S)-8-[(dimethylamino)methyl]-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-[6-[4-[(8S,11R,14S,17R)-17-acetyl-17-acetyloxy-3-oxo-2,6,7,8,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-11-yl]-N-methylanilino]hexanoyl]piperazine-1-carboxylate.

Molecular Properties

Compound Name[(19S)-8-[(dimethylamino)methyl]-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-[6-[4-[(8S,11R,14S,17R)-17-acetyl-17-acetyloxy-3-oxo-2,6,7,8,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-11-yl]-N-methylanilino]hexanoyl]piperazine-1-carboxylate
PubChem CID165146163
Molecular FormulaC62H72N6O11
Molecular Weight1077.29 g/mol
Exact Mass1076.53
IUPAC Name[(19S)-8-[(dimethylamino)methyl]-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-[6-[4-[(8S,11R,14S,17R)-17-acetyl-17-acetyloxy-3-oxo-2,6,7,8,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-11-yl]-N-methylanilino]hexanoyl]piperazine-1-carboxylate
SMILESCC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(OC(=O)N4CCN(C(=O)CCCCCN(C)c5ccc([C@H]6CC7[C@@H](CC[C@]7(OC(C)=O)C(C)=O)[C@@H]7CCC8=CC(=O)CCC8=C76)cc5)CC4)ccc3nc2-1
InChIInChI=1S/C62H72N6O11/c1-7-61(76)50-32-53-57-40(33-68(53)58(73)49(50)35-77-59(61)74)30-47-48(34-64(4)5)54(21-20-52(47)63-57)78-60(75)67-27-25-66(26-28-67)55(72)11-9-8-10-24-65(6)41-15-12-38(13-16-41)46-31-51-44(22-23-62(51,36(2)69)79-37(3)70)45-18-14-39-29-42(71)17-19-43(39)56(45)46/h12-13,15-16,20-21,29-30,32,44-46,51,76H,7-11,14,17-19,22-28,31,33-35H2,1-6H3/t44-,45-,46+,51?,61-,62-/m0/s1
InChIKeyZOAZFTPLUZLAOM-JBAFGQRESA-N
XLogP7.88
TPSA198.19 Ų
H-Bond Donors1
H-Bond Acceptors15
Rotatable Bonds14
Heavy Atoms79
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001077.29
LogP ≤ 57.88
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_E(186)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze [(19S)-8-[(dimethylamino)methyl]-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-[6-[4-[(8S,11R,14S,17R)-17-acetyl-17-acetyloxy-3-oxo-2,6,7,8,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-11-yl]-N-methylanilino]hexanoyl]piperazine-1-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(19S)-8-[(dimethylamino)methyl]-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-[6-[4-[(8S,11R,14S,17R)-17-acetyl-17-acetyloxy-3-oxo-2,6,7,8,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-11-yl]-N-methylanilino]hexanoyl]piperazine-1-carboxylate?
The IUPAC name of [(19S)-8-[(dimethylamino)methyl]-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-[6-[4-[(8S,11R,14S,17R)-17-acetyl-17-acetyloxy-3-oxo-2,6,7,8,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-11-yl]-N-methylanilino]hexanoyl]piperazine-1-carboxylate (CID 165146163) is [(19S)-8-[(dimethylamino)methyl]-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-[6-[4-[(8S,11R,14S,17R)-17-acetyl-17-acetyloxy-3-oxo-2,6,7,8,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-11-yl]-N-methylanilino]hexanoyl]piperazine-1-carboxylate.
What is the SMILES notation for [(19S)-8-[(dimethylamino)methyl]-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-[6-[4-[(8S,11R,14S,17R)-17-acetyl-17-acetyloxy-3-oxo-2,6,7,8,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-11-yl]-N-methylanilino]hexanoyl]piperazine-1-carboxylate?
The canonical SMILES for [(19S)-8-[(dimethylamino)methyl]-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-[6-[4-[(8S,11R,14S,17R)-17-acetyl-17-acetyloxy-3-oxo-2,6,7,8,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-11-yl]-N-methylanilino]hexanoyl]piperazine-1-carboxylate is CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(OC(=O)N4CCN(C(=O)CCCCCN(C)c5ccc([C@H]6CC7[C@@H](CC[C@]7(OC(C)=O)C(C)=O)[C@@H]7CCC8=CC(=O)CCC8=C76)cc5)CC4)ccc3nc2-1.
What is the InChIKey of [(19S)-8-[(dimethylamino)methyl]-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-[6-[4-[(8S,11R,14S,17R)-17-acetyl-17-acetyloxy-3-oxo-2,6,7,8,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-11-yl]-N-methylanilino]hexanoyl]piperazine-1-carboxylate?
The InChIKey is ZOAZFTPLUZLAOM-JBAFGQRESA-N. The full InChI is InChI=1S/C62H72N6O11/c1-7-61(76)50-32-53-57-40(33-68(53)58(73)49(50)35-77-59(61)74)30-47-48(34-64(4)5)54(21-20-52(47)63-57)78-60(75)67-27-25-66(26-28-67)55(72)11-9-8-10-24-65(6)41-15-12-38(13-16-41)46-31-51-44(22-23-62(51,36(2)69)79-37(3)70)45-18-14-39-29-42(71)17-19-43(39)56(45)46/h12-13,15-16,20-21,29-30,32,44-46,51,76H,7-11,14,17-19,22-28,31,33-35H2,1-6H3/t44-,45-,46+,51?,61-,62-/m0/s1.
What are the key properties of [(19S)-8-[(dimethylamino)methyl]-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-[6-[4-[(8S,11R,14S,17R)-17-acetyl-17-acetyloxy-3-oxo-2,6,7,8,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-11-yl]-N-methylanilino]hexanoyl]piperazine-1-carboxylate?
[(19S)-8-[(dimethylamino)methyl]-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-[6-[4-[(8S,11R,14S,17R)-17-acetyl-17-acetyloxy-3-oxo-2,6,7,8,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-11-yl]-N-methylanilino]hexanoyl]piperazine-1-carboxylate has a molecular weight of 1077.29 g/mol, XLogP of 7.88, 14 rotatable bonds, 1 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for [(19S)-8-[(dimethylamino)methyl]-19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-[6-[4-[(8S,11R,14S,17R)-17-acetyl-17-acetyloxy-3-oxo-2,6,7,8,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-11-yl]-N-methylanilino]hexanoyl]piperazine-1-carboxylate is sourced from PubChem (CID 165146163), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).